Shilpi Arora

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 343 citations · Full text

Drug-tolerant Cancer Cells, Medicine, Anti-cancer Agent +7

MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration

Shilpi Arora, Aarati R. Ranade, Nhan L. Tran et al. · International Journal of Cancer · 2011 · 175 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation

William D. Bradley, Shilpi Arora, Jennifer Busby et al. · Chemistry & Biology · 2014 · 148 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +10

Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes

John P. McGrath, Kaylyn E. Williamson, Srividya Balasubramanian et al. · Cancer Research · 2016 · 123 citations · Full text

Histone Modifications, Mixed-phenotype Acute Leukemia, Epigenetic Change +18

Identification of differentially expressed genes in oral squamous cell carcinoma

Shilpi Arora, Ajay Matta, Nootan Kumar Shukla et al. · Molecular Carcinogenesis · 2004 · 107 citations

Oral Carcinogenesis, Oral Potentially Malignant Disorders, Oncogenic Agent +15